Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal versus extra-amniotic intrauterine misoprostol for second-trimester abortion induction
IRCT20190606043830N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of misoprostol in missed abortion and stillbirth (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Time to expulsion of gestational products. Started Jun 2019; status: completed.
02
Drugs
misoprostol
03
Conditions
missed abortionstillbirth
Beyond the preview
Go deeper on IRCT20190606043830N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190606043830N1.